JSJCX
Price
$14.33
Change
+$0.12 (+0.84%)
Updated
Sep 11 closing price
Net Assets
514.56M
NRGSX
Price
$59.88
Change
+$0.37 (+0.62%)
Updated
Sep 11 closing price
Net Assets
6.95B
Interact to see
Advertisement

JSJCX vs NRGSX

JSJCX vs NRGSX Comparison Chart in %
View a ticker or compare two or three
VS
JSJCX vs. NRGSX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSJCX is a Buy and NRGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 6.95B vs. JSJCX (515M). NRGSX pays higher dividends than JSJCX: NRGSX (0.44) vs JSJCX (0.00). JSJCX was incepted earlier than NRGSX: JSJCX (8 years) vs NRGSX (14 years). JSJCX (2.14) is less costly to investors than NRGSX (0.74). JSJCX is a more actively managed with annual turnover of: 141.00 vs. NRGSX (23.00). NRGSX has a lower initial minimum investment than JSJCX: NRGSX (0) vs JSJCX (1000). NRGSX annual gain was more profitable for investors over the last year : -8.11 vs. JSJCX (-11.74). NRGSX return over 5 years is better than : -23.14 vs. JSJCX (-44.42).
JSJCXNRGSXJSJCX / NRGSX
Total Expense Ratio1.940.74262%
Annual Report Gross Expense Ratio2.140.74289%
Fund Existence8 years14 years-
Gain YTD2.08311.42518%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets515M6.95B7%
Annual Yield % from dividends0.000.44-
Returns for 1 year-11.74-8.11145%
Returns for 3 years15.032.69558%
Returns for 5 years-44.42-23.14192%
Returns for 10 yearsN/A10.53-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEVA37.090.74
+2.04%
Teva Pharmaceutical Industries Limited
UFPI80.560.36
+0.45%
UFP Industries
DSGN14.63-0.17
-1.15%
Design Therapeutics
BRCB8.48-0.27
-3.09%
Black Rock Coffee Bar Inc
SINT1.80-0.06
-3.23%
SiNtx Technologies Inc.